What medicines are used for RA and PsA?
Managing inflammatory conditions like Rheumatoid Arthritis and Psoriatic Arthritis requires a combination of medications designed to reduce pain, control inflammation, and prevent long-term joint damage. Because these are autoimmune diseases where the immune system mistakenly attacks healthy tissue, the treatment approach focuses on dampening this overactive response. Modern medicine provides several tiers of therapy that allow clinicians to tailor treatment to the severity of the condition, aiming to achieve remission and maintain physical function for the patient.
What We’ll Discuss in This Article
- The role of Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
- Biological treatments and how they target specific proteins
- The use of corticosteroids for rapid symptom control
- Pain relief options including NSAIDs and analgesics
- The importance of the “treat-to-target” approach in medication
- Monitoring for safety and side effects during long-term therapy
The medicines used for RA and PsA are primarily focused on suppressing the immune system to stop it from attacking the joints, a process led by specialist medications known as DMARDs. While pain relief and anti-inflammatory drugs provide immediate comfort by reducing swelling and aches, they do not stop the underlying disease from progressing. Consequently, rheumatologists prioritize the use of disease-modifying therapies as the foundation of treatment to protect the bone and cartilage from irreversible structural changes.
Disease-Modifying Anti-Rheumatic Drugs (DMARDs)
DMARDs are the first line of treatment for both Rheumatoid Arthritis and Psoriatic Arthritis because they actively interfere with the biological processes causing the inflammation. Unlike simple painkillers, these drugs can take several weeks or even months to reach their full effect. The NHS states that DMARDs work by blocking the effects of the chemicals released when your immune system attacks your joints, which could otherwise cause further damage to nearby bones, tendons, ligaments, and cartilage.
The most common conventional DMARD is methotrexate, which is often used as the “anchor” drug in treatment plans. Other medications in this category include leflunomide, sulfasalazine, and hydroxychloroquine. Doctors may prescribe these drugs individually or in combination to achieve better control over the inflammation. Because these medicines affect the immune system, patients require regular blood tests to monitor liver function and blood cell counts.
Biological and Targeted Synthetic Treatments
When conventional DMARDs are not effective enough on their own, specialists may move to biological treatments. These are newer, highly specific medications that block individual proteins in the immune system, such as TNF-alpha, which are responsible for driving the inflammatory response. According to the NHS, biological treatments are usually taken in combination with methotrexate or another DMARD and are usually given by injection.
In addition to biologicals, there is a newer class of medications known as JAK inhibitors. These are targeted synthetic DMARDs taken in tablet form that block the signaling pathways inside immune cells. These advanced therapies are strictly regulated and are usually reserved for patients who have moderate to severe disease activity that hasn’t responded to standard treatments.
Corticosteroids for Acute Flares
Corticosteroids, such as prednisolone, are powerful anti-inflammatory medicines used to provide rapid relief during a flare-up or while waiting for DMARDs to start working. They can be taken as tablets, given as an injection directly into an inflamed joint, or administered as an intramuscular injection. While highly effective at reducing swelling and stiffness almost immediately, they are generally used at the lowest possible dose for the shortest time.
Long-term use of steroids is avoided where possible due to the risk of side effects, including bone thinning, weight gain, and increased blood pressure. Specialists use them as a “bridge” therapy to manage symptoms quickly while the long-term disease-modifying drugs are being adjusted. Once the DMARDs have taken control of the inflammation, the steroid dose is usually tapered down slowly under medical supervision.
Pain Relief and Anti-Inflammatories
Non-steroidal anti-inflammatory drugs (NSAIDs) and simple analgesics are used to manage the daily symptoms of pain and stiffness. While these do not stop joint damage, they are essential for maintaining mobility and quality of life. Common NSAIDs include ibuprofen, naproxen, and etoricoxib, which work by reducing the production of prostaglandins that cause pain and swelling.
Doctors may also prescribe cox-2 inhibitors, which are a type of NSAID designed to be gentler on the stomach. It is common for patients to use these medicines alongside their disease-modifying treatments during periods of increased activity. However, long-term use of NSAIDs is monitored closely due to potential impacts on the heart, kidneys, and digestive system.
Comparison of Medication Roles
The following table illustrates the different functions of the primary drug classes used in RA and PsA management.
| Medication Type | Main Function | Time to Work |
| Conventional DMARDs | Stop underlying disease progression | 6 to 12 weeks |
| Biologicals | Target specific immune proteins | 2 to 6 weeks |
| Corticosteroids | Rapidly suppress intense flares | 24 to 48 hours |
| NSAIDs | Reduce pain and daily swelling | 30 to 60 minutes |
| JAK Inhibitors | Block internal cell signals | 2 to 4 weeks |
Conclusion
The medicinal management of RA and PsA involves a tiered approach that prioritizes disease-modifying drugs to protect joint structures while using anti-inflammatories and steroids for symptom control. Successful treatment often requires a combination of therapies tailored to the individual’s disease activity and response to initial drugs. Consistent monitoring through blood tests and specialist reviews ensures that these powerful medications are used safely and effectively. If you experience severe, sudden, or worsening symptoms, call 999 immediately.
Can I stop my medication if my joints feel better?
No, you should never stop disease-modifying drugs without medical advice, as the inflammation can return and cause hidden damage even if you feel fine.
Why do I need blood tests every few months?
Regular blood tests are essential to check that your medications are not affecting your liver, kidneys, or blood cell counts.
What is the difference between a biosimilar and a biological drug?
A biosimilar is a highly similar version of an original biological medicine that works in the same way and meets the same safety standards.
Is it safe to take ibuprofen with methotrexate?
You should only take NSAIDs with DMARDs if they have been specifically approved by your rheumatologist, as they can occasionally interact.
Will I be on these medicines for the rest of my life?
RA and PsA are chronic conditions, so most people require long-term medication to keep the disease in remission and prevent damage.
Why does it take so long for DMARDs to work?
These drugs work by changing the way your immune system functions at a cellular level, which is a slow biological process.
Can these medications affect my ability to fight infections?
Yes, because they dampen the immune system, you may be more prone to infections and should seek medical advice if you develop a fever or feel unwell.
Authority Snapshot (E-E-A-T Block)
This guide provides evidence-based information on the medications used for inflammatory arthritis, strictly adhering to NHS and NICE clinical guidelines. The content is authored by the Medical Content Team and reviewed by Dr. Rebecca Fernandez, a UK-trained physician with extensive experience in internal medicine and emergency care. We aim to support public health by explaining the clinical roles and safety requirements of RA and PsA treatments.
